View Post

U.S. Prepares for Sudan Ebolavirus Potential Arrival

In COVID-19, Latest News by Precision Vaccinations

The U.S. CDC's Clinician Outreach and Communication Activity call on October 12, 2022, offered an emergency update on Uganda's ongoing Sudan Ebolavirus (SUDV) outbreak.
Led by Trevor Shoemaker, Ph.D., MPH, and Mary Choi, MD, MPH, this CDC presentation call reviewed the SUDV outbreak in Mubende District, which was declared on September 20, 2022.
Since then, Uganda's Ministry of Health has confirmed nineteen people have died from SUDV, indicating a case fatality rate of about 40%.
Before 2022, there were seven SUDV outbreaks, with 792 cases and 426 related deaths.

View Post

U.S. NIH Launches Second Monkeypox Treatment Study

In COVID-19, Latest News by Precision Vaccinations

The U.S. National Institutes of Health (NIH) announced yesterday that a clinical trial evaluating the antiviral drug TPOXX (tecovirimat) had begun in the Democratic Republic of the Congo (DRC).
The phase 2 clinical trial evaluates TPOXX's safety and ability to mitigate monkeypox symptoms and prevent serious outcomes, including death.